A new retrospective study on COVID-19 among cancer patients, focusing on risk factors associated with admission to the intensive care unit (ICU) has been conducted by a team of clinicians from 3 hospitals in Wuhan, China, and recently published in the Annals of Oncology. Clinical data gathered from 28 cancer patients with COVID-19 infection between January 13, 2020 - February 26, 2020 indicates that 17 patients (60%) were male, with an average age of 65 years. Of the 28 cancer patients studied, 7 (25%) had lung cancer, followed by oesophageal cancer (4 patients), and breast cancer (3 patients). 10 patients had a stage IV cancer diagnosis and 8 patients developed COVID-19 from hospital-associated transmission. Further, of the 6 patients who received anti-tumour treatment within 14 days of their COVID-19 diagnosis, 5 (83%) developed severe events.
To read more about this study, click here.
Study mentioned: Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Annals of Oncology; Published online 23 March 2020. DOI: https://doi.org/10.1016/j.annonc.2020.03.296
No comments:
Post a Comment